INMUNE BIO, INC.

Analyst Reco. INmune Bio, Inc.

Equities

INMB

US45782T1051

Market Closed - Nasdaq Other stock markets 21:00:00 30/04/2024 BST			5-day change	1st Jan Change
11.84 ^USD	+0.59%		+16.77%	+5.15%

04-29	INmune Bio Inc. Completes First Cohort and Initiates Second Cohort of Phase 1/2 Study of INKmune?? Natural Killer Cell Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer	CI
04-23	Inmune Bio Inc. Announces 24-Month Stability Validation of Xpro? for Phase III Readiness and Commercial Supply Chain Modeling & Development of Novel Immunogenicity Assay	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Baird Initiates INmune Bio at Outperform With $16 Price Target	01/06/23	MT
INmune Bio Shares Rebound From 52-Week Low, Up 9%	25/05/22	DJ
INmune Bio Shares Hit 52-Week Low After FDA Requests More Data on XPro1595	24/05/22	DJ
BTIG Adjusts INmune Bio's Price Target to $14 From $31, Reiterates Buy Rating	24/05/22	MT
B. Riley Downgrades INmune Bio to Neutral from Buy on Chemistry Manufacturing and Controls-Related FDA Hold, Lowers Price Target to $7 from $14	24/05/22	MT
B. Riley Lowers INmune Bio's Price Target to $14 from $20, Notes Higher Cost of Capital; Keeps Buy Rating	08/03/22	MT
B. Riley Lowers INmune Bio's Price Target to $20 from $32 After Revising Cost Capital Assumptions, Keeps Buy Rating	24/01/22	MT
INMUNE BIO : B. Riley Raises INmune Bio's PT to $32 from $26, Notes 'Encouraging' Datasets From 2 Lead Programs; Keeps Buy Rating	07/09/21	MT
INMUNE BIO : B. Riley Lowers INmune Bio's PT to $26 from $34 on Revised Costs and Timeline for AD Development, Keeps Buy Rating	06/08/21	MT
INMUNE BIO : B. Riley Raises INmune Bio's PT to $34 from $29 Driven by Pipeine Progress, Simplification of Capital Structure; Keeps Buy Rating	14/07/21	MT
INMUNE BIO : B. Riley Starts INmune Bio at Buy with $29 PT; Says Breast Cancer, Alzheimer's Programs Represent Potential Upside to Model	21/04/21	MT
INMUNE BIO : HC Wainwright Adjusts INmune Bio's Price Target to $15 from $20, Keeps Buy Rating	09/11/20	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Securing my Investments

fermer